MedPath

Azelastine Hydrochloride

These highlights do not include all the information needed to use AZELASTINE HYDROCHLORIDE NASAL SPRAY safely and effectively. See full prescribing information for AZELASTINE HYDROCHLORIDE NASAL SPRAY.AZELASTINE HYDROCHLORIDE nasal spray, for intranasal use Initial U.S. Approval: 1996

Approved
Approval ID

fc69f672-17ec-4d86-b5af-086fd260b512

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 1, 2022

Manufacturers
FDA

Akorn

DUNS: 117696873

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Azelastine Hydrochloride

PRODUCT DETAILS

NDC Product Code50383-942
Application NumberANDA210032
Marketing CategoryC73584
Route of AdministrationNASAL
Effective DateMarch 1, 2022
Generic NameAzelastine Hydrochloride

INGREDIENTS (8)

AZELASTINE HYDROCHLORIDEActive
Quantity: 1.5 mg in 1 mL
Code: 0L591QR10I
Classification: ACTIB
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
TRISODIUM CITRATE DIHYDRATEInactive
Code: B22547B95K
Classification: IACT
SORBITOLInactive
Code: 506T60A25R
Classification: IACT
SUCRALOSEInactive
Code: 96K6UQ3ZD4
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Azelastine Hydrochloride - FDA Drug Approval Details